{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:24:15Z","timestamp":1790605455917,"version":"4.1.0"},"reference-count":87,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2556,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1111\/j.1365-2354.2008.00917.x","type":"journal-article","created":{"date-parts":[[2008,7,8]],"date-time":"2008-07-08T11:58:23Z","timestamp":1215518303000},"page":"431-443","source":"Crossref","is-referenced-by-count":165,"title":["Therapeutic use of<i>Cannabis sativa<\/i>on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis"],"prefix":"10.1155","volume":"17","author":[{"given":"F.C.","family":"MACHADO ROCHA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"ST\u00c9FANO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"DE C\u00c1SSIA HAIEK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.Q.","family":"ROSA OLIVEIRA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.X.","family":"DA SILVEIRA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB1","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/0024-3205(95)00194-B","article-title":"An efficient new cannabinoid anti-emetic in pediatric oncology","volume":"56","author":"Abrahamov","year":"1995","journal-title":"Life Sciences"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB2","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/j.1360-0443.1996.tb02264.x","article-title":"Cannabis: pharmacology and toxicology in animals and humans","volume":"91","author":"Adams","year":"1996","journal-title":"Addiction"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/bjc.1983.247","article-title":"Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy","volume":"48","author":"Ahmedzai","year":"1983","journal-title":"British Journal of Cancer"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB4","first-page":"1022","article-title":"Prevention of chemotherapy- and radiotherapy-induced emesis: results of the Perugia Consensus Conference","volume":"9","author":"Anti-emetic Subcommitee of the Multinational Association of Supportive Care in Cancer (MASCC","year":"1998","journal-title":"Annals of Oncology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0305-7372(84)90010-0","article-title":"Advances in anti-emetic therapy","volume":"11","author":"Barowski","year":"1984","journal-title":"Cancer Treatment Reviews"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB6","volume-title":"The Marijuana Conviction: A History of Marijuana Prohibition in the United States","author":"Bonnie","year":"1974"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB7","first-page":"946","article-title":"Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial","volume":"79","author":"Chan","year":"1987","journal-title":"Pediatrics"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/0003-4819-91-6-819","article-title":"Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation","volume":"91","author":"Chang","year":"1979","journal-title":"Annals of Internal Medicine"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB9","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/1097-0142(19810401)47:7<1746::AID-CNCR2820470704>3.0.CO;2-4","article-title":"A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy","volume":"47","author":"Chang","year":"1981","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB10","first-page":"109","article-title":"Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting","volume":"69","author":"Citron","year":"1985","journal-title":"Cancer Treatment Report"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB11","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(80)91642-6","article-title":"Cannabis and cancer chemotherapy","volume":"i","author":"Colls","year":"1980","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB12","first-page":"449","article-title":"The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy","volume":"91","author":"Colls","year":"1980","journal-title":"The New Zealand Medical Journal"},{"issue":"Suppl. B","key":"10.1111\/j.1365-2354.2008.00917.x-BIB13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0305-7372(82)80038-8","article-title":"Use of nabilone in the treatment of chemotherapy-induced vomiting in an outpatient setting","volume":"9","author":"Cone","year":"1982","journal-title":"Cancer Treatment Reviews"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF02934575","article-title":"Nabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinun: a double blind study","volume":"3","author":"Crawford","year":"1986","journal-title":"Medical Oncology and Tumor Pharmacotherapy"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB15","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.1002\/j.1552-4604.1981.tb02572.x","article-title":"Anti-emetic effect of intramuscular levonantradol in patients receiving anticancer chemotherapy","volume":"21","author":"Cronin","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB16","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1136\/bmj.291.6499.864","article-title":"Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs","volume":"291","author":"Cunningham","year":"1985","journal-title":"British Medical Journal"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0277-5379(88)90300-8","article-title":"A randomised trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues","volume":"24","author":"Cunningham","year":"1988","journal-title":"European Journal of Cancer Clinical Oncology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB18","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/adc.61.5.502","article-title":"Nabilone: an alternative anti-emetic for cancer chemotherapy","volume":"61","author":"Dalzell","year":"1986","journal-title":"Archives of Disease in Childhood"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0893-133X(00)00197-4","article-title":"Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB (1) receptor antagonist\/inverse agonist SR 141716A","volume":"24","author":"Darmani","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB20","first-page":"319","article-title":"Adverse reactions to delta-9-tetrahydrocannabinol given as an antiemetic in a multicenter study","volume":"6","author":"Devine","year":"1987","journal-title":"Clinical Pharmacology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB21","doi-asserted-by":"crossref","first-page":"81S","DOI":"10.1002\/j.1552-4604.1981.tb02579.x","article-title":"Oral levonantradol in the treatment of chemotherapy-induced emesis: preliminary observations","volume":"21","author":"Diasio","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB22","first-page":"143","article-title":"The control of cancer chemotherapy-induced nausea and vomiting","volume":"10","author":"Dodds","year":"1985","journal-title":"Journal of Clinical Hospital Pharmacology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0305-7372(82)80037-6","article-title":"Nabilone: an effective anti-emetic agent in patients receiving cancer chemotherapy","volume":"9","author":"Einhorn","year":"1982","journal-title":"Cancer Treatment Reviews"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/j.1552-4604.1981.tb02576.x","article-title":"Nabilone: an effective antiemetic in patients receiving cancer chemotherapy","volume":"21","author":"Einhorn","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.5694\/j.1326-5377.1979.tb127271.x","article-title":"Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol","volume":"2","author":"Ekert","year":"1979","journal-title":"Medical Journal of Australia"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.pharmtox.38.1.179","article-title":"Cannabinoid receptors and their endogenous agonists","volume":"38","author":"Felder","year":"1998","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0091-3057(98)00114-2","article-title":"Cannabimimetic activity in rats and pigeons of HU 210, a potent antiemetic drug","volume":"62","author":"Ferrari","year":"1999","journal-title":"Pharmacological, Biochemistry and Behavior"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/07357908409040312","article-title":"Pharmacologic treatment of chemotherapy-induced nausea and vomiting","volume":"2","author":"Fiori","year":"1984","journal-title":"Cancer Investigation"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-91-6-825","article-title":"Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo","volume":"91","author":"Fritak","year":"1979","journal-title":"Annals of Internal Medicine"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB30","first-page":"203","article-title":"Two-pronged study of tetrahydrocannabinol (THC) prevention of vomiting from cancer chemotherapy","volume":"8","author":"Garb","year":"1980","journal-title":"IRCS Medical Science"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB31","first-page":"24","article-title":"Randomised comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin","volume":"37","author":"George","year":"1983","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB32","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1002\/1097-0142(19951201)76:11<2330::AID-CNCR2820761122>3.0.CO;2-F","article-title":"Randomised, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based anti-emetic regimen in patients undergoing autologous bone marrow transplantation","volume":"76","author":"Gilbert","year":"1995","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB33","first-page":"163","article-title":"Anti-emetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol","volume":"68","author":"Gralla","year":"1984","journal-title":"Cancer Treatment Report"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB34","first-page":"55","volume-title":"Pharmacology, Toxicology and Therapeutic Potential","author":"Grotenhermen","year":"2002"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB35","first-page":"55","volume-title":"Pharmacology, Toxicology and Therapeutic Potential","author":"Grotenhermen","year":"2002"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB36","doi-asserted-by":"crossref","first-page":"86S","DOI":"10.1002\/j.1552-4604.1981.tb02580.x","article-title":"Clinical experience with levonantradol hydrochloride in the prevention of cancer chemotherapy-induced nausea and vomiting","volume":"21","author":"Heim","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB37","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJM197906073002302","article-title":"Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy","volume":"300","author":"Herman","year":"1979","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB38","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/BF01880638","article-title":"New perspective in antiemetic treatment","volume":"4","author":"Herstedt","year":"1996","journal-title":"Support Care Cancer"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB39","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1055\/s-2008-1070107","article-title":"Levonantradol bei der Behandlung von zytostatika-bedingter \u00dcbelkeit und Erbrechen","volume":"107","author":"Higi","year":"1982","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB40","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0277-5379(83)90032-9","article-title":"A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapy","volume":"19","author":"Hutcheon","year":"1983","journal-title":"European Journal of Cancer Clinical Oncology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomised clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0305-7372(82)80032-7","article-title":"A double-blind, controlled trial of nabilone vs prochlorperazine for refractory emesis induced by cancer chemotherapy","volume":"9","author":"Johansson","year":"1982","journal-title":"Cancer Treatment Reviews"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0305-7372(82)80035-2","article-title":"A multi-institutional phase III study of nabilone vs placebo in chemotherapy-induced nausea and vomiting","volume":"9","author":"Jones","year":"1982","journal-title":"Cancer Treatment Reviews"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB44","first-page":"131","volume-title":"Depend\u00eancia de Drogas","author":"Karniol","year":"2000"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB45","first-page":"335","article-title":"Levonantradol effectiveness in cancer patients resistant to conventional anti-emetics","volume":"8","author":"Kenny","year":"1982","journal-title":"Clinical Oncology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB46","first-page":"228","article-title":"Delta-9-tetrahydrocannabinol (THC) as an antiemetic for patients receiving cancer chemotherapy; a double blind cross-over trial against placebo","volume":"21","author":"Kluin-Neleman","year":"1979","journal-title":"Veterinary and Human Toxicology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB47","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1200\/JCO.1985.3.10.1379","article-title":"Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin","volume":"3","author":"Kris","year":"1985","journal-title":"Journal of Clinical Oncology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB48","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00000421-199012000-00006","article-title":"Dronabinol and prochlorperazine alone and in combination as antiemetic agents for cancer chemotherapy","volume":"13","author":"Lane","year":"1990","journal-title":"American Journal of Clinical Oncology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB49","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0885-3924(91)90026-Z","article-title":"Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting","volume":"6","author":"Lane","year":"1991","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB50","doi-asserted-by":"crossref","first-page":"51S","DOI":"10.1002\/j.1552-4604.1981.tb02573.x","article-title":"Levonantradol for chemotherapy-induced emesis: phase I-II oral administration","volume":"21","author":"Laszlo","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0305-7372(82)80036-4","article-title":"Nabilone vs placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients","volume":"9","author":"Levitt","year":"1982","journal-title":"Cancer Treatment Reviews"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB52","doi-asserted-by":"crossref","first-page":"103S","DOI":"10.1002\/j.1552-4604.1981.tb02583.x","article-title":"Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10, and 15\u2003mg of \u03949-tetrahydrocannabinol in cancer chemotherapy. Ophthalmologic implications","volume":"21","author":"Levitt","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB53","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jama.1980.03300380021014","article-title":"\u03949-tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy","volume":"243","author":"Lucas","year":"1980","journal-title":"Journal of the American Medical Association"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB54","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0009-9260(82)80383-8","article-title":"Randomised clinical trial of levonantradol and chlorpromazine in the prevention of radiotherapy-induced vomiting","volume":"33","author":"Lucraft","year":"1982","journal-title":"Clinical Radiology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB55","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00008877-199605000-00008","article-title":"The endogenous cannabinoid receptor agonist anandamide impairs memory in rats","volume":"7","author":"Mallet","year":"1996","journal-title":"Behavioral Pharmacology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB56","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00175407","article-title":"Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy","volume":"6","author":"McCabe","year":"1988","journal-title":"Investigational New Drugs"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB57","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/bmj.316.7128.333","article-title":"Quantitative systematic review of topically-applied non-steroidal anti-inflamatory drugs","volume":"316","author":"Moore","year":"1998","journal-title":"British Medical Journal"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB58","volume-title":"The Cochrane Library","author":"Mulrow","year":"1997"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB59","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/j.1552-4604.1981.tb02571.x","article-title":"Comparative trial of the antiemetic effects of THC and haloperidol","volume":"21","author":"Neidhart","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB60","first-page":"276","article-title":"Nabilone in the management of prochlorperazine resistant cancer chemotherapy induced emesis","volume":"77","author":"Niamatali","year":"1984","journal-title":"Irish Medical Journal"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB61","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/BF01728184","article-title":"Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy","volume":"64","author":"Niederle","year":"1986","journal-title":"Klinische Wochenschrift"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB62","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00000421-198708000-00014","article-title":"Antiemetic efficacy of nabilone and dexamethasone: a randomized study of patients with lung cancer receiving chemotherapy","volume":"10","author":"Niiranen","year":"1987","journal-title":"American Journal of Clinical Oncology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB63","first-page":"140","article-title":"Two decades of progress in treating chemotherapy induced emesis","volume":"28","author":"Olver","year":"2004","journal-title":"Cancer Forum"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB64","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/oxfordjournals.annonc.a010798","article-title":"A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis","volume":"7","author":"Olver","year":"1996","journal-title":"Annals of Oncology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB65","doi-asserted-by":"crossref","first-page":"76S","DOI":"10.1002\/j.1552-4604.1981.tb02578.x","article-title":"Antiemetic effect of \u03949-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine","volume":"21","author":"Orr","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB66","first-page":"355","volume-title":"Psychotropic Drugs of Abuse","author":"Pertwee","year":"1990"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB67","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0024-3205(99)00282-9","article-title":"Evidence for the presence of CB1 cannabinoid receptors on peripheral neurons and for the existence of neuronal non-CB1 cannabinoid receptors","volume":"65","author":"Pertwee","year":"1999","journal-title":"Life Sciences"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB68","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2174\/0929867306666220401124036","article-title":"Pharmacology of cannabinoid receptor ligants","volume":"6","author":"Pertwee","year":"1999","journal-title":"Current Medicinal Chemistry"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB69","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00256701","article-title":"Prospective randomised double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis","volume":"17","author":"Pomeroy","year":"1986","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB70","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(80)92844-5","article-title":"Cannabis: a medical question?","volume":"1","author":"Rose","year":"1980","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB71","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJM197510162931603","article-title":"Anti-emetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy","volume":"293","author":"Sallan","year":"1975","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB72","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJM198001173020302","article-title":"Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine","volume":"302","author":"Sallan","year":"1980","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB73","first-page":"5","article-title":"Chemotherapy-induced nausea and vomiting: clinician and patient perspectives","volume":"5","author":"Schwartzberg","year":"2007","journal-title":"Journal of Support Oncology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB74","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/j.1552-4604.1984.tb01824.x","article-title":"Double-blind multiple-dose cross-over study of the antiemetic effect of intramuscular levonantradol compared to prochlorperazine","volume":"24","author":"Sheidler","year":"1984","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB75","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/j.1552-4604.1984.tb02756.x","article-title":"Dose ranging evaluation of the antiemetic efficacy of intramuscular levonantradol in cancer subjects with chemotherapy-induced emesis","volume":"24","author":"Stambaugh","year":"1984","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB76","first-page":"219","article-title":"Double-blind comparison of the anti-emetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis","volume":"64","author":"Steele","year":"1980","journal-title":"Cancer Treatment Report"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB77","doi-asserted-by":"crossref","first-page":"70S","DOI":"10.1002\/j.1552-4604.1981.tb02577.x","article-title":"\u03949-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A pilot study","volume":"21","author":"Sweet","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB78","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0028-3908(94)90018-3","article-title":"Enatioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994","volume":"33","author":"Tattersall","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.323.7303.16","article-title":"Cannabinoids for control of chemotherapy-induced nausea and vomiting: quantitative systematic review","volume":"323","author":"Tram\u00e8r","year":"2001","journal-title":"British Medical Journal"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB80","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00000421-198512000-00014","article-title":"Phase 1 trial of levonantradol in chemotherapy-induced emesis","volume":"8","author":"Tyson","year":"1985","journal-title":"American Journal of Clinical Oncology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB81","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/1097-0142(19820815)50:4<636::AID-CNCR2820500404>3.0.CO;2-4","article-title":"Cannabis and cancer therapy: a comparison of delta-9-THC and prochlorperazine","volume":"50","author":"Ungerleider","year":"1982","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB82","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00000421-198504000-00006","article-title":"THC or compazine for the cancer chemotherapy patient - the UCLA study. Part II: patient drug preference","volume":"8","author":"Ungerleider","year":"1985","journal-title":"American Journal of Clinical Oncology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB83","first-page":"525","article-title":"Inhalation marijuana as an antiemetic for cancer chemotherapy","volume":"88","author":"Vinciguerra","year":"1988","journal-title":"New York State Journal of Medicine"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB84","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0305-7372(82)80034-0","article-title":"Double-blind, randomised, crossover trial of nabilone vs. placebo in cancer chemotherapy","volume":"9","author":"Wada","year":"1982","journal-title":"Cancer Treatment Reviews"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB85","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00520-002-0387-7","article-title":"Established and potential therapeutic applications of cannabinoids in oncology","volume":"11","author":"Walsh","year":"2003","journal-title":"Support Care Cancer"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB86","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF00257422","article-title":"Oral levonantradol in the control of cancer chemotherapy-induced emesis","volume":"11","author":"Welsh","year":"1983","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"10.1111\/j.1365-2354.2008.00917.x-BIB87","first-page":"1601","article-title":"Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma","volume":"66","author":"Wilcox","year":"1982","journal-title":"Cancer Treatment Report"}],"container-title":["European Journal of Cancer Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2354.2008.00917.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2354.2008.00917.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:50:11Z","timestamp":1684468211000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2354.2008.00917.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2354.2008.00917.x","relation":{},"ISSN":["0961-5423","1365-2354"],"issn-type":[{"value":"0961-5423","type":"print"},{"value":"1365-2354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}